Stockreport

Veru Healthcare Presents Results from Phase 4 Clinical Study of PREBOOST for Management of Premature Ejaculation

FEMALE HEALTH  (FHCO) 
US:NASDAQ Investor Relations: verupharma.com/investors
PDF Analysis of men treated with PREBOOST® (topical 4% benzocaine wipes) showed statistically greater improvement in control of ejaculation, sati [Read more]